SRAX, Inc. SRAX Cash Flow

Srax, inc. (SRAX)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
Cash Flows From Operating Activities
Net income (loss)
-3,003	-4,385	1,410	-8,098	-5,786	-8,517	21,271	-4,021	11	-6,851	-2,682	-1,524	-1,973	-1,343	-2,375	1,873	-2,401	-426	-658	415	-2,054	-1,925	-917	-880	-687	-262	-829	-277	-377	-465	-316	-249	-226
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of put warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (loss) on sale of assets
-	-	-	-	472	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of stock based prepaid fees
-	-	-	-	-	-	-	-	-	-	-	-	-	0	56	158	158	158	158	158	158	158	158	168	168	152	65	9	9	9	9	9	29
Stock based compensation
260	392	328	325	121	122	595	995	166	1,138	326	108	512	589	150	181	277	213	179	188	258	968	87	82	65	138	420	36	37	10	10	11	10
Gain/Loss on valuation of warrant derivatives
-	-	-	-	-	-	-	1,013	-3,723	-	-	-	-1,947	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of SRAXmd
-	-	-	-	-	-	-	-	-22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt issue costs
17	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative liabilities
1,302	-	-	-	-1,962	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt issuance costs
-	-	-	-	-	-	30	206	93	716	-67	-144	578	259	250	271	294	327	297	308	319	-	-	-	0	0	127	112	34	0	0	0	0
Amortization of debt discount
-	-	-	-	-	3,089	587	276	342	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
PIK Interest expense accrued to principal
-	-	-	-	-	-	-	-	-	-	-	-	-	63	206	121	120	111	102	88	88	63	0	0	0	-	-	-	-	-	-	-	-
Digital currency assets impairment loss
-	-	-	-	-	-	-	-	-	-	0	0	468	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of contingent consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-3,744	40	118	160	241	230	220	-	-	-	0	-	-	-	-	-	-	-	-
Accretion of put liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	41	-	-	-	0	-	-	-	-	-	-	-	-
Accretion of put liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	16	47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	194	4	4	-	-	-	-	-	-	-	-	-	-	-	-
Provision for bad debts
15	-	-	-	-	-3	-3	-5	-0	-31	-142	-13	-8	23	19	71	5	20	15	43	7	26	0	0	0	-	-	-	-	-	-	-	-
Depreciation expense
19	21	19	17	16	13	10	10	9	8	8	2	3	4	3	3	9	-	-	-	-	-	3	3	2	2	1	1	1	1	1	0	0
Amortization of intangibles
-	-	-	-	-	-	-	183	166	-	132	118	107	-	89	89	89	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of intangibles
290	-	-	-	237	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities
Accounts receivable
-275	-175	-656	471	-1,278	857	-186	984	-2,614	-2,883	-542	1,005	-1,840	4,050	988	3,830	-2,051	-1,814	-198	5,092	208	937	426	150	-317	-39	159	227	39	-335	-148	-118	-157
Prepaid expenses
-71	37	-14	58	25	18	149	-25	72	-73	217	-6	-2	104	-94	19	-5	178	-11	-35	-45	146	16	26	-17	46	0	0	0	-85	17	9	58
Other current assets
-5	5	-56	0	-30	95	116	-0	3	-	-	-	-	0	0	-4	-25	13	20	0	-4	-24	4	0	2	-0	0	0	0	0	-0	0	0
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	6	0	4	0	0	0	0	0	0	0	0	-	-	-	-
Accounts payable and accrued expenses
553	675	-1,525	-1,064	-299	-97	-5,146	2,318	-178	-5,813	337	-863	-195	1,665	3,155	4,130	-930	-578	-2,094	4,625	303	1,014	351	38	-542	-284	543	144	110	45	-158	-24	4
Unearned revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-19	-25	41	1	-0	-20	14	-17	25	0	0	0	-	-	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	80	-124	1,863	-1,356	1,064	-831	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Used in Operating Activities
-2,799	-2,795	-4,062	-5,553	-2,939	-4,742	-8,366	-1	-552	-2,126	86	-1,715	-611	-	-	-	-	-	-	-	-	-	-	-	-661	-261	168	-162	-222	21	-325	-182	-83
Cash Flows From Investing Activities
Proceeds from sale of SRAXmd, net
-	263	-88	-77	473	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of property and equipment
-	-	-	-	20	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of equipment
-	-	-	-	-	52	9	0	20	24	83	8	5	28	0	4	0	-	-	-	-	0	0	0	6	19	0	0	0	-	-	-	-
Development of software
278	400	348	263	280	259	250	219	231	180	184	135	135	119	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
65	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of SRAXmd
-	-	-	-	-	-	-	-	22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4	0	-2	-30	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Used by Investing Activities
-213	-65	-528	-373	172	-352	22,698	-197	-274	-205	-267	-143	-141	-	-	-	-	-	-	-	-	-	-	-	-6	-19	0	0	0	-	-	-	-
Cash Flows From Financing Activities
Proceeds from issuance of notes payable less issuance costs
3,090	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the issuance of common stock units
-	-	-	-	-	-	-	-	-	200	0	0	3,820	1,092	3,050	0	500	-	-	-	0	2,677	0	0	1,273	2,436	0	0	0	0	0	0	472
Repayments of notes payable
-	-	-	-	-	-	-	-	-	0	0	0	3,996	2,000	395	1,001	366	3,202	595	251	315	0	0	0	0	371	42	79	57	0	0	0	0
Cost of common stock sale
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16	-	-	-	-	-	-	-	-
Cost of common stock sale
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9	14	0	0	-	-	-	-
Proceeds from warrant offering
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	2	0	0	0	-	-	-	-	-	-	-	-
Proceeds from notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	2,100	1,400	1,500	0	0	-	-	-	-	0	0	228	257	0	0	0	0
Payment of contingent consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1,600	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Debt issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	10	25	0	0	0	0
Net cash provided by (used in) financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,001	633	-1,802	904	-251	-308	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Provided by Financing Activities
3,090	-	-	-	-	-	-	-	-	3,132	0	2,136	-176	-	-	-	-	-	-	-	-	-	-	-	1,256	1,851	-56	139	174	0	0	0	472
Net increase (decrease) in Cash
78	-	-	-	-2,767	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase / (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-148	-827	800	-180	277	-929	-3,192	3,566	-925	509	58	-482	812	-1,140	1,266	-963	-763	588	1,569	111	-23	-48	21	-325	-200	389
Supplemental disclosure of cash flow information:
Cash paid for interest
52	-4	39	44	56	772	445	-26	340	568	0	98	550	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	281	325	415	255	241	221	157	0	0	0	0	19	14	3	0	0	0	0
Cash paid for taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-20	0	20	-	0	0	0	0	0	0	0	0	0	-38	0	0	0	38	0
Noncash investing and financing activities:
Vesting of prepaid common stock award
94	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Relative fair value of warrants issued with term loan
83	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares of common stock issued for extension agreement
71	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock issued for vested grants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Put liability on issuance of warrants
-	-	-	-	-	-	-	-	-	-	0	0	2,500	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fees and costs deducted from proceeds of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	21	42	0	0	0	0
Common stock issued as payment of financing fee
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	75	100	0	0	0	0
Issuance of common stock to be issued
-	-	-	-	-	0	10	0	869	-	-	-	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock issued for preferred stock conversion and vesting grants
-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	2,400	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Vesting of common stock award
-	-	-	-	-	-	0	0	150	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contribution of member interests (net assets) in Social Reality, LLC in exchange for common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	147	0	0	575